Finally, notwithstanding the complexity of the mechanism of action of PTX3 on different molecular and cellular components of the tumor and host, our results support the hypothesis that anti-FGF/FGFR strategies may exert a therapeutic effect in fibrosarcoma. This evidence concerns the gene PTX3 and fibrosarcoma.